Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hologic Inc (NASDAQ:HOLX)

38.45
Delayed Data
As of Sep 23
 -0.33 / -0.85%
Today’s Change
31.84
Today|||52-Week Range
41.66
-0.62%
Year-to-Date
Hologic (HOLX) Stock Higher, Barclays Upgrades
Sep 23 / TheStreet.com - Paid Partner Content
Hologic: FDA OKs Expanded Emergency Use of Zika Virus Test
Sep 13 / Zacks.com - Paid Partner Content
3 Commercial Labs Fighting Zika Threat to Bet On
Sep 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close38.78
Today’s open39.30
Day’s range38.31 - 39.30
Volume2,635,904
Average volume (3 months)2,678,438
Market cap$10.7B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+650.00%
Earnings growth (this year)+16.23%
Earnings growth (next 5 years)+9.29%
Revenue growth (last year)+6.89%
P/E ratio42.3
Price/Sales4.28
Price/Book5.22

Competitors

 Today’s
change
Today’s
% change
ALOGAnalogic Corp+0.25+0.27%
VRAYViewray Inc-0.61-11.49%
GTHPGuided Therapeutics ...+0.00+9.09%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)$0.50
Annual revenue (last year)$2.7B
Annual profit (last year)$131.6M
Net profit margin4.87%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Stephen P. MacMillan
Chief Operating Officer
Eric B. Compton
Corporate headquarters
Marlborough, Massachusetts

Forecasts

Search for Jobs